Alphamab Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Suzhou China (2009)

Organization Overview

First Clinical Trial
2017
NCT03101488
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alphamab (Australia) Co Pty Ltd. | Alphamab Jilin Co., Ltd. | Jiangsu Alphamab Biopharmaceuticals Co., Ltd